Novo Nordisk A/S  

(Public, CPH:NOVO-B)   Watch this stock  
Find more results for NOVO-B
242.00
+0.40 (0.17%)
Real-time:   9:59AM GMT+2
CPH real-time data - Disclaimer
Currency in DKK
Range 240.30 - 242.40
52 week 169.60 - 265.30
Open 241.90
Vol / Avg. 259,061.00/2.54M
Mkt cap 538.61B
P/E 25.88
Div/yield 4.50/1.86
EPS 9.35
Shares 2.23B
Beta     -
Inst. own     -
Mar 17, 2014
Novo Nordisk A/S Annual Shareholder Meeting
  

Key stats and ratios

Q4 (Dec '13) 2013
Net profit margin 27.90% 30.13%
Operating margin 33.89% 37.68%
EBITD margin - 41.03%
Return on average assets 35.07% 37.03%
Return on average equity 59.44% 60.54%
Employees 37,978 -
CDP Score - 96 B

Address

Novo Alle
BAGSVAERD, 2880
Denmark
+45-44-448888 (Phone)
+45-44-436633 (Fax)

Website links

External links

Description

Novo Nordisk A/S is a healthcare company. The Company is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. It is engaged in diabetes care. It has a range of diabetes product portfolio, including a portfolio of modern insulins and the first human once-daily GLP-1 analog. In addition, it has is engaged in areas, such as haemophilia, growth hormone therapy and hormone replacement therapy. It manufactures and markets pharmaceutical products and services to patients, the medical profession and society. The Company operates in two segments: diabetes care and biopharmaceuticals. In February 2014, Innate Pharma has acquired full development and commercialization rights to the anti-NKG2A antibody, a immune checkpoint inhibitor ready for Phase II development in oncology from Novo Nordisk.

Officers and directors

Goran A. Ando M.D. Chairman of the Board
Age: 64
Kaare Schultz President, Chief Operating Officer
Age: 52
Lars Rebien Soerensen Chief Executive Officer
Age: 59
Jeppe Christiansen Vice Chairman of the Board
Age: 54
Jesper Brandgaard Chief Financial Officer, Executive Vice President
Age: 50
Lars Fruergaard Joergensen Executive Vice President, Chief Information Officer
Age: 47
Mads Krogsgaard Thomsen Chief Science Officer, Executive Vice President
Age: 53
Jakob Riis Executive Vice President of Marketing & Medical Affairs
Age: 47
Lise Kingo Executive Vice President, Chief of Staffs
Age: 52
Liselotte Hyveled Director, Employee Representative